Pyrosequencing Further Courts Molecular Diagnostics Market Through Mycobacterium Pact With Cleveland Clinic | GenomeWeb

NEW YORK, Nov. 5 — A unit of Swedish genomic firm Pyrosequencing and The Cleveland Clinic Foundation announced plans on Monday to co-develop rapid identification and diagnostic tests for mycobacteria. 

This partnership, which was launched to create faster and higher-quality tests for diagnosing and identifying Mycobacterium tuberculosis  and Mycobacterium avium,  is part of Pyrosequencing’s broad plan to enter the molecular diagnostic-testing arena. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.